Biblio

Export 223 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is E  [Clear All Filters]
Journal Article
R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
A. Suzuki, Shinozaki, J., Yazawa, S., Ueki, Y., Matsukawa, N., Shimohama, S., and Nagamine, T., “Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1653-1665, 2018.
E. N. Paterson, Williams, M. A., Passmore, P., Silvestri, G., MacGillivray, T. J., Maxwell, A. P., and McKay, G. J., “Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1379-1385, 2017.
B. Imtiaz, Tolppanen, A. Maija, Solomon, A., Soininen, H., and Kivipelto, M., “Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 453-458, 2017.
M. Guglielmotto, Manassero, G., Vasciaveo, V., Venezia, M., Tabaton, M., and Tamagno, E., “Estrogens Inhibit Amyloid-β-Mediated Paired Helical Filament-Like Conformation of Tau Through Antioxidant Activity and miRNA 218 Regulation in hTau Mice.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1339-1351, 2020.
M. Smedinga, Tromp, K., Schermer, M. H. N., and Richard, E., “Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1309-1322, 2018.
J. Noel M. Viaña, Bittlinger, M., and Gilbert, F., “Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 2, pp. 289-301, 2017.
A. D. Watt, Jenkins, N. L., McColl, G., Collins, S., and Desmond, P. M., “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
S. Ismail Shiekh, Cadogan, S. Louise, Lin, L. - Y., Mathur, R., Smeeth, L., and Warren-Gash, C., “Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 80, no. 1, pp. 337-355, 2021.
C. Agyemang, van de Vorst, I. E., Koek, H. L., Bots, M. L., Seixas, A., Norredam, M., Ikram, U., Stronks, K., and Vaartjes, I., “Ethnic Variations in Prognosis of Patients with Dementia: A Prospective Nationwide Registry Linkage Study in The Netherlands.”, J Alzheimers Dis, vol. 56, no. 1, pp. 205-213, 2017.
D. Jara-Moreno, Castro-Torres, R. D., Ettcheto, M., Auladell, C., Kogan, M. J., Folch, J., Verdaguer, E., Cano, A., Busquets, O., Delporte, C., and Camins, A., “The Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer's Disease in Female APPswe/PS1dE9 Mice Fed with a High Fat Diet.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1175-1191, 2018.
N. Samudra, Ranasinghe, K., Kirsch, H., Rankin, K., and Miller, B., “Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps.”, J Alzheimers Dis, vol. 92, no. 1, pp. 13-27, 2023.
A. Marra, Naro, A., Chillura, A., Bramanti, A., Maresca, G., De Luca, R., Manuli, A., Bramanti, P., and Calabrò, R. Salvatore, “Evaluating Peripersonal Space through the Functional Transcranial Doppler: Are We Paving the Way for Early Detecting Mild Cognitive Impairment to Dementia Conversion?”, J Alzheimers Dis, vol. 62, no. 1, pp. 133-143, 2018.
D. Lambracht-Washington, Fu, M., Wight-Carter, M., Riegel, M., and Rosenberg, R. N., “Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.”, J Alzheimers Dis, vol. 57, no. 1, pp. 97-112, 2017.
V. Chouraki, Reitz, C., Maury, F., Bis, J. C., Bellenguez, C., Yu, L., Jakobsdottir, J., Mukherjee, S., Adams, H. H., Choi, S. Hoan, Larson, E. B., Fitzpatrick, A., Uitterlinden, A. G., De Jager, P. L., Hofman, A., Gudnason, V., Vardarajan, B., Ibrahim-Verbaas, C., van der Lee, S. J., Lopez, O., Dartigues, J. - F., Berr, C., Amouyel, P., Bennett, D. A., van Duijn, C., DeStefano, A. L., Launer, L. J., M Ikram, A., Crane, P. K., Lambert, J. - C., Mayeux, R., and Seshadri, S., “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
N. Sakae, Heckman, M. G., Vargas, E. R., Carrasquillo, M. M., Murray, M. E., Kasanuki, K., Ertekin-Taner, N., Younkin, S. G., and Dickson, D. W., “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
G. Tuna, Yener, G. Gülmen, Oktay, G., İşlekel, G. Hüray, and Kİrkalİ, F. Güldal, “Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1265-1273, 2018.
E. Lee, Gatz, M., Tseng, C., Schneider, L. S., Pawluczyk, S., Wu, A. H., and Deapen, D., “Evaluation of Medicare Claims Data as a Tool to Identify Dementia.”, J Alzheimers Dis, vol. 67, no. 2, pp. 769-778, 2019.
M. Ettcheto, Petrov, D., Pedrós, I., Alva, N., Carbonell, T., Beas-Zarate, C., Pallas, M., Auladell, C., Folch, J., and Camins, A., “Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 233-51, 2016.
L. Lahme, Esser, E. Luisa, Mihailovic, N., Schubert, F., Lauermann, J., Johnen, A., Eter, N., Duning, T., and Alnawaiseh, M., “Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1745-1752, 2018.
X. Wang, Li, F., Gao, Q., Jiang, Z., Abudusaimaiti, X., Yao, J., and Zhu, H., “Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.”, J Alzheimers Dis, vol. 87, no. 1, pp. 285-304, 2022.
J. M. Jiang, Seng, E. K., Zimmerman, M. E., Sliwinski, M., Kim, M., and Lipton, R. B., “Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults.”, J Alzheimers Dis, vol. 59, no. 3, pp. 987-996, 2017.
I. E. van de Vorst, Koek, H. L., Bots, M. L., and Vaartjes, I., “Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning.”, J Alzheimers Dis, vol. 53, no. 1, pp. 117-25, 2016.

Pages